Jenett, Bruce


Partner, DLA Piper

bruce.jenettATdlapiperDOTcom

Bruce Jenett focuses his practice on the representation of US and international business and finance clients in the life sciences industry.

He is highly experienced in equity and debt financing, licensing and distribution, strategic alliances, joint ventures, and mergers and acquisitions, as well as general counseling issues, representing both startups and large multinational corporations. Mr. Jenett has, for example, represented clients in one of the largest (in financial terms) ag-bio partnering deals in history, and one of the largest (also in financial terms) partnering deals done by an Irish venture capital-backed biotechnology company with a major pharmaceutical company. Abingworth Management, Inc., Astellas Venture Capital LLC, Bayer Corporation and Bayer AG, CardioGenesis Corporation, Exelixis, Inc., IntegenX Inc., Intellikine, Inc., Novo Ventures (US), Inc., OptiMedica Corporation, TPG Ventures, VisionCare Ophthalmic Technologies, Inc., and several startup incubators have been among his clients.

Mr. Jenett is a frequent speaker on corporate and finance issues to both business and attorney audiences. He is a member of the board of directors of BayBio and has been a member of and was chair of the Strategic Planning Committee of former San Francisco Mayor Gavin Newsom's Biotech Advisory Council. From 2008 to 2012, Mr. Jenett served as co-chair of DLA Piper's Global Life Sciences Sector.

Chambers USA: America's Leading Lawyers for Business, by the respected research publisher Chambers & Partners, consistently names Mr. Jenett one of the leading life sciences lawyers in the United States. Chambers has noted his "strong and broad-based" practice and quoted clients saying that he "is truly a full-services life sciences lawyer.'"

The PLC Which Lawyer? Yearbook 2009 cites Mr. Jenett as "highly recommended" in the area of life sciences, noting he is "known for his strong venture capital and collaborative expertise," and he is named a recommended practitioner in the PLC Cross-border Life Sciences Handbook in 2009, 2010 and 2011. Mr. Jenett has been repeatedly listed as a leading biotechnology industry lawyer in The Best Lawyers In America in biotechnology law; has been named on the Law & Politics Super Lawyers list for Northern California for corporate and securities law in every year since 2007, when the list began; is listed in The International Who's Who of Life Sciences Lawyers 2008; in the 2011 Who's Who Legal - The International Who's Who of Life Sciences Lawyers; in the San Francisco Business Times 2009 "Best Lawyers in The Bay Area" and "Best Biotechnology Lawyers," in the 2012 San Francisco Chronicle "San Francisco's Best Lawyers" in the biotechnology category, and in California's Best Lawyers in 2012, and was named California Life Sciences Attorney of the Year in 2011 at the Corporate INTL magazine 2011 Global Awards. Mr. Jenett is also featured as a Life Sciences Star in the inaugural edition of LMG's Life Sciences 2012.

Listen to an interview with Bruce



New to Mendelspod?

We advance life science research, connecting people and ideas.
Register here to receive our newsletter.

or skip signup